Grantham, Mayo, Van Otterloo & Co (GMO)’s Broadridge BR Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio BR Stock Details BR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,840	Closed	-$690K	–	611
2025 Q2	$690K	Buy	+2,840	New	+$675K	﹤0.01%	513
2018 Q4	–	Sell	-2,000	Closed	-$264K	–	538
2018 Q3	$264K	Sell	2,000 -46,997	-96%	-$5.97M	﹤0.01%	494
2018 Q2	$5.64M	Buy	48,997 +4,297	+10%	+$485K	0.04%	198
2018 Q1	$4.9M	Buy	+44,700	New	+$4.44M	0.03%	227
2017 Q2	–	Sell	-17,300	Closed	-$1.18M	–	585
2017 Q1	$1.18M	Sell	17,300 -14,088	-45%	-$955K	0.01%	360
2016 Q4	$2.08M	Sell	31,388 -24,348	-44%	-$1.58M	0.01%	314
2016 Q3	$3.78M	Sell	55,736 -168,570	-75%	-$11.5M	0.02%	276
2016 Q2	$14.6M	Buy	224,306 +187,906	+516%	+$11.6M	0.06%	197
2016 Q1	$2.16M	Buy	+36,400	New	+$1.99M	0.01%	363
2014 Q2	–	Sell	-34,500	Closed	-$1.28M	–	503
2014 Q1	$1.28M	Sell	34,500 -1,107	-3%	-$41.5K	﹤0.01%	459
2013 Q4	$1.41M	Buy	35,607 +15,425	+76%	+$557K	﹤0.01%	434
2013 Q3	$641K	Buy	20,182 +8,015	+66%	+$238K	﹤0.01%	513
2013 Q2	$323K	Buy	+12,167	New	+$313K	﹤0.01%	585

Other funds holding BR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s BR Position: Q3 2025 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Broadridge (BR) in Q3 2025, closing a stake of 2,840 shares — an estimated $690K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in BR in Q2 2013 and held it in 13 quarters. The position peaked at $14.6M in Q2 2016. 1,107 funds tracked by Wall St. Rank hold BR as of Q3 2025.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Broadridge position as of Q3 2025 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 2,840 Broadridge shares in Q3 2025, an estimated $690K.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Broadridge in Q2 2013 and held it in 13 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Broadridge position peaked at $14.6M in Q2 2016.
1,107 funds tracked by Wall St. Rank held Broadridge as of Q3 2025.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2025, filed 13 Nov 2025.